DiabeCell: Additional Phase I/IIa data

Additional data from a Russian Phase I/IIa trial in 8 patients showed that DiabeCell implant reduced HbA1c in 6 patients by 0.2-2.8% and reduced daily insulin by 13-100% at 6 months. In 5 patients rec...